Clinical trial

ERG Components in Schizophrenia and Bipolar Disorder Type I

NCT03788811

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2018-07-05

PhaseN/A

Study timeline

Study start (actual)2018-07-05Date precision: day

Registry last updated2025-08-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Bipolar I Disorderunresolved

Interventions

ERG assessment (RSPA)DEVICE

Sponsors & collaborators

diaMentis Inc.lead sponsor

Mapped research locations

MontrealQuebec, Canada2 TorontoOntario, Canada1 RochesterNew York, United States1 TorranceCalifornia, United States1 MelbourneVictoria, Australia1 Staten IslandNew York, United States1 KingstonOntario, Canada1 Garden GroveCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03788811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.